Rare diseases
Investigational molecules
Locations
Study on the Effects of BI 685509 for Patients with Liver Cirrhosis and Portal Hypertension After First Decompensation Event
FranceStudy Comparing Zimberelimab and Domvanalimab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory Lymphomas After CAR T-cell Therapy
FranceStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy of Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone for Patients with Newly Diagnosed AL Amyloidosis with Heart Involvement
FranceStudy on the Long-term Safety and Effects of AL002 and Florquinitau F18 in Patients with Alzheimer's Disease
FranceStudy of ALE.C04 and Pembrolizumab for Adults with Recurrent or Metastatic Head and Neck Cancer
FranceStudy on the Safety and Effectiveness of Pembrolizumab, Vibostolimab, and Lenvatinib for Patients with PD-1 Refractory Melanoma
FranceStudy Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer
FranceStudy on Vilobelimab and Drug Combination for Treating Ulcerative Pyoderma Gangrenosum in Adults
FranceStudy on the Safety and Effects of Risdiplam for Adults and Children with Spinal Muscular Atrophy
FranceStudy of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
